Want to see TDOC full AI Analyst Report?
TDOC Stock Chart & Stats
$5.69
-$0.30(-3.00%)
At close: 4:00 PM EST
$5.69
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$4.40 - $9.89
Previous CloseN/A
Volume1.13M
Average Volume (3M)4.10M
Market Cap
$1.70B
Enterprise Value$1.26K
Total Cash (Recent Filing)$750.74M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Jul 29, 2026EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding180,513,090
10 Day Avg. Volume3,615,109
30 Day Avg. Volume4,103,224
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$7.25Price Target Upside27.42% Upside
Rating ConsensusHold
Number of Analyst Covering16
EPS Forecast (FY)-0.91
Revenue Forecast (FY)$2.51B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationConsistent positive TTM operating cash flow and FCF provide durable internal funding for operations, strategic investments, and debt reduction. This cash conversion lessens reliance on equity raises, supports execution of multi-quarter initiatives and improves runway during cyclical revenue variability.
Integrated Care Scale And Margin ImprovementIntegrated Care’s large covered-membership and sequential margin expansion indicate structural strength: membership scale supports stable subscription/contract revenue, enables cross-sell of chronic programs, and drives operating leverage that can sustainably lift consolidated margins over multiple quarters.
BetterHelp Insurance Rollout MomentumShifting BetterHelp toward insurance is a structural revenue-model change: contracting >150M lives and credentialing providers creates recurring insurer-paid sessions, higher early-session engagement, and better monetization per user, which can meaningfully rebase psychiatric/therapy revenue over the medium term.
Bears Say
Ongoing Negative ProfitabilitySustained negative operating and net income metrics mean Teladoc still must convert revenue growth into profitable operations. Persistent negative margins and returns strain capital allocation choices, limit reinvestment potential, and increase sensitivity to revenue disappointments over multiple quarters.
BetterHelp Cash-pay Declines And User LossDeclining cash-pay revenue and paying users reflect structural demand shifts and create durable headwinds to margins, since lower-value cash sessions and mix changes erode profitability. Successful long-term recovery depends on insurance conversion and sustained user engagement gains.
High Gross Debt And Convertible Note MaturityMaterial gross leverage and a near-term convertible-note maturity create structural capital-structure risk. Even with improving net leverage, execution to reduce gross debt is required; failure to execute could force costly refinancing or constrain strategic flexibility over the next several quarters.
Teladoc News
TDOC FAQ
What was Teladoc Inc.’s price range in the past 12 months?
Teladoc Inc. lowest stock price was $4.40 and its highest was $9.89 in the past 12 months.
What is Teladoc Inc.’s market cap?
Teladoc Inc.’s market cap is $1.70B.
When is Teladoc Inc.’s upcoming earnings report date?
Teladoc Inc.’s upcoming earnings report date is Jul 29, 2026 which is in 10 days.
How were Teladoc Inc.’s earnings last quarter?
Teladoc Inc. released its earnings results on Apr 29, 2026. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.341 by -$0.019.
Is Teladoc Inc. overvalued?
According to Wall Street analysts Teladoc Inc.’s price is currently Undervalued.
Does Teladoc Inc. pay dividends?
Teladoc Inc. does not currently pay dividends.
What is Teladoc Inc.’s EPS estimate?
Teladoc Inc.’s EPS estimate is -0.25.
How many shares outstanding does Teladoc Inc. have?
Teladoc Inc. has 180,513,090 shares outstanding.
What happened to Teladoc Inc.’s price movement after its last earnings report?
Teladoc Inc. reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.341. Following the earnings report the stock price went up 1.849%.
Which hedge fund is a major shareholder of Teladoc Inc.?
Currently, no hedge funds are holding shares in TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.25 (27.42% Upside)
$7.25 (27.42% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 689.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.3%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.28%
12-Months-Change
Fundamentals
Return on Equity
-12.37%
Trailing 12-Months
Asset Growth
-18.50%
Trailing 12-Months
Company Description
Teladoc Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
TDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$7.25
▲(27.42% Upside)
Technical Analysis
Ownership Overview
0.66% Insiders
21.58% Mutual Funds
<0.01% Other Institutional Investors
56.44% Public Companies and Individual Investors